Piedmont HealthCare is dedicated to improving health care in our community and advancing the medical field through clinical research.
Clinical Research
WHAT
Clinical trials are designed to collect pivotal knowledge about investigational medications, the effectiveness of medical devices, the potential for new cancer screening options that may benefit future patients and current research participants. The trials are designed to assess both the safety and effectiveness of a product and are conducted under rigorous U.S. Food and Drug Administration (FDA) guidelines. Information or data during the study is reviewed to ensure its safety or effectiveness. That data is then submitted to the FDA, which reviews the data and approves or denies a new drug, device, or test to go to market.
WHY
- Improving healthcare outcomes for patients
- Reducing the cost of healthcare to patients and across the system
- Improving patient engagement and satisfaction with their healthcare experience
By participating, you may contribute to the healthcare of tomorrow and take a step towards improving and educating yourself about your own health. You may have a positive impact on the health of millions — perhaps even your own friends and loved ones. Research studies can allow you access to medical options and medications not available through any other means. Compensation may be offered.
HOW
Piedmont HealthCare patients are eligible to enroll in clinical trials in a few different ways
- Review our clinical trials to see if any apply to you and your medical situation. Fill out an interest form. Our team will outreach you to let you know if you qualify to enroll. Our goal is to match patients with clinical trials that are right for you.
- Your doctor may talk to you about clinical studies or recommend you for a specific trial.
- Our research department may reach out if they feel you are a good fit.
Once enrolled in a study, there will be specific criteria and instructions to complete the trial.
FAQs
Are clinical trials safe?
Yes. Before starting the trial, you will be given an informed consent form outlining the details of the research study. This form includes information on why the study is being conducted, how long it will last, procedures you may need to undergo, contact information, risks, and possible benefits. In addition, as stated above, all clinical studies follow rigorous FDA rules.
How many studies can I be part of?
You can take part in as many clinical studies as you qualify for, but you can only be part of one study at a time.
What if I don’t qualify for a study?
If you don’t qualify for a specific study, that’s okay. There will be other studies for you to take part in.
Are there questions I should ask before I say yes to a clinical trial?
• Why is this trial being conducted?
• Should I tell my family doctor that I’m part of a study?
• Does the new medicine treat any other conditions?
• Is there a possibility I will receive a placebo?
• Can I take my current prescriptions during the study?
• How much does the study cost?
• What if I decide I don’t want to be part of the study?
• How do I tell my friends and family about clinical research?
Open Studies
*In partnership with Innovo*
Medical Condition: Patients who are planning to do a standard of care LDCT lung cancer screening or standard of care Colonoscopy.
Facility: 340 Signal Hill Dr., Suite C, Statesville
Age: For Lung cancer screening 50-80 years of age / for screening Colonoscopy 45-85 years of age.
Gender: M/F
Enrollment: Patient
Commitment Duration: up to 3 years
Number of Visits in Study: up to 3 visits
Patient compensation will be available
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: standard of care cancer screening for lung, and cancer.
Facility: 340 Signal Hill Dr., Suite C, Statesville OR 125 Days Inn Dr. Mooresville
Age: 50-80
Gender: M/F
Description: Screening for High Frequency Malignant Disease in patients prior to lung cancer screening.
Commitment Duration: Up to 2 years
Number of visits in study: 1-3
Patient compensation will be available.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Low-dose CT Lung Cancer Screening
Medical Condition: standard of care screening for lung, and cancer.
Facility: 340 Signal Hill Dr., Suite C, Statesville OR 125 Days Inn Dr. Mooresville
Age: 50 and older
Gender: M/F
Description: a blood-based testing in conjunction with standard of care low-dose CT lung cancer screening.
Commitment Duration: up to 5 years
Number of visits: up to 2
Patient compensation will be available.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Asthma Study
Medical Condition: Diagnosis of Asthma
Facility: Remote with Internet/WiFi Connection
Age: 12 years and older
Gender: M/F
Description: An asthma study for patients actively using inhalers to reduce or control asthma symptoms.
Commitment: 52 weeks
Number of Visits: 8
Patient compensation will be available.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Chronic kidney disease with hypertension (Arctic and Pacific)
Facility: 340 Signal Hill Drive—Dr. Moran and Dr. Dwight Bellingham
Age: >18 years of age
Gender: M/F
Enrollment: Patient
Commitment Duration: Approximately 2 years
Number of Visits in Study: 11-13
Patient compensation will be available: You will be paid $150 per completed Screening Visit, $100-$200 for every other completed study visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: DNA colorectal screening
Facility: 340 Signal Hill Drive—Blood draw only for patients with upcoming colonoscopies scheduled
Age: 45-84
Gender: M/F
Enrollment: Patient
Commitment Duration: 1 visit
Number of Visits in Study: 1
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Screening LDCT for current or former smokers
Facility: 340 Signal Hill Drive—Blood draw only for patients who have had screening LDCT in 12 months or plan to have one in the next 6 weeks.
Age: >50
Gender: M/F
Enrollment: Patient
Commitment Duration: 1 year, only one visit and one chart review done at 12months
Number of Visits in study: 1
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Radiological finding and/or clinical evaluation that indicates suspicion of lung cancer diagnosis. Confirmed, untreated cancer
Facility: 340 Signal Hill Drive—Blood draw only for patients
Age: 50+
Gender: M/F
Enrollment: Patient
Commitment Duration: 1 year, only one visit and one chart review done at 12months
Number of Visits in study: 1
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Progressive pulmonary fibrosis
Facility: 208 Old Mocksville Road- Pulmonology all doctors on this study
Age: 18+
Gender: M/F
Enrollment: Patient
Commitment Duration: Up to 58 weeks
Number of Visits in study: 11
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Adult participants with high-risk asthma
Facility: 208 Old Mocksville Road- Dr. Perez, Dr. V. Patel
Age: 18-80
Gender: M/F
Enrollment: Patient
Commitment Duration: Approximately 64 weeks
Number of Visits in study: 18
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Pediatric patients with asthma
Facility: 208 Old Mocksville Road
Age: 4-17
Gender: M/F
Enrollment: Patient
Commitment Duration: The study is event driven so will close once certain number of exacerbations occur could last up to 24 months
Number of Visits in study: 8
Patient compensation will be available:
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Mild to moderate Ulcerative colitis
Facility: 340 Signal Hill Drive and 208 Old Mocksville Road
Age: 18-75
Gender: M/F
Enrollment: Patient
Commitment Duration: Approximately 1 year
Number of Visits in study: Approximately 16
Patient compensation will be available: $100 for regular onsite visits and $250 (inclusive of the $100 stipend above) for visits where an Colonoscopy or Sigmoidoscopy occurs. You will be paid following each completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Mild cognitive impairment—Parkinson’s or Alzheimer’s
Facility: 340 Signal Hill Drive—Blood draw only for patients
Age: 40+ for Alzheimer’s; 18+ for Parkinson’s
Gender: M/F
Enrollment: Patient
Commitment Duration: 1 visit
Number of Visits in study: 1 visit
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Chronic Spontaneous Urticaria
Facility: 340 Signal Hill Drive, Statesville, NC 28625
Age: 18+
Gender: M/F
Enrollment: Patient
Commitment Duration: 16 weeks
Number of Visits in study: 9 visits
Patient compensation will be available: You will be paid $100 per completed visit.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Alzheimer’s
Facility: 340 Signal Hill Drive, Statesville, NC 28625; 375 Hospital St Ste 200, Mocksville, NC 27028
Age: 60+
Gender: M/F
Enrollment: Patient
Commitment Duration: Approximately 72 weeks of treatment period and up to 5 years of observation
Number of Visits in study: Approximately 21
This study has two enrollment options one being observational monitor SOC treatments. Second option is a infusion treatment option.
Patient compensation will be available.
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Innovo*
Medical Condition: Chronic Heart Failure (CHF)
Facility: 633 Brookdale Drive, Suite 100, Statesville—Dr. Rajper
Age: 18+
Gender: M/F
Enrollment: Patient
Commitment Duration: This is data driven and will last 1-5 years
Number of Visits in study: 11+
Patient compensation will be available: Enrollment and compensation pending
For additional inquiries or if you have any questions, please call 704-660-1231 or email kayleen.murphy@piedmonthealthcare.com
*In partnership with Accellacare*
Medical Condition: Covid Vaccine
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Active
Commitment Duration: 1-year, weekly nasal swabs post vaccination
Number of Visits in study: 6 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Non-Cirrhotic Nonalcoholic Steatohepatitis(NASH)/Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Facility: 208 Old Mocksville
Age: 18-80
Gender: M/F
Enrollment: Active
Commitment Duration: 240 weeks: After enrollment visits are weekly for the first 4 weeks on treatment then monthly. After week 52 they are every 12 weeks
Number of Visits in study: 25 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Painful diabetic peripheral neuropathy
Facility: 138 Old Sherlock Dr
Age: >18
Gender: M/F
Enrollment: Active
Commitment Duration: 41 weeks, 10 office visits, 2 phone call visits, and 2 eye exams
Number of Visits in study: 12 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Focal Epilepsy
Facility:
Age: 18-75
Gender: M/F
Enrollment: Active
Commitment Duration: 14 weeks: 2 eye exams
Number of Visits in study: 7 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity with Type II Diabetes
Facility: 208 Old Mocksville Rd
Age: 40-80
Gender: M/F
Enrollment: Active
Commitment Duration: 53 Weeks: 17 in office visits and 36 weekly in office dosing visits, 1 eye exam and 2 optional Full Body MRI
Number of Visits in study: Up to 53
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Chronic Obstructive Pulmonary Disease
Facility: 208 Old Mocksville Rd
Age: 40-80
Gender: M/F
Enrollment: Active
Commitment Duration: 3 years,3 visits within first month, then every 3 months for the first year and every 6 months until end of study.
Number of Visits in study: Up to 11 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Pediatric Migraines
Facility: 208 Old Mocksville Rd
Age: 6-12 years old
Gender: M/F
Enrollment: Starting Jun 2025
Commitment Duration: 28 days, 4 office visits, 2 phone call visits
Number of Visits in study: 6 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity or Overweight
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Starting May 2025
Commitment Duration: About 2 years, Full Body DXA preformed 5 time and a MRI preformed 3 times throughout the study.
Number of Visits in study: 25 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Elevated LDL with Atherosclerotic Cardiovascular Disease
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Upcoming
Commitment Duration: 1 year, all in office visits, no phone call visits
Number of Visits in study: 11 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity or Overweight without Diabetes
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Starting in July 2025
Commitment Duration: 42 weeks
Number of Visits in study: 18 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity or Overweight with Type II Diabetes
Facility: 208 Old Mocksville Rd
Age: >18
Gender: M/F
Enrollment: Starting in August 2025
Commitment Duration: 34 weeks, 1 eye exam
Number of Visits in study: 16 Visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Obesity or Overweight without Diabetes
Facility: 138 Sherlock Dr.
Age: >18
Gender: M/F
Enrollment: Starting in August 2025
Commitment Duration: 3.5 years, includes a 80-week open label extension phase for weight maintenance.
Number of Visits in study: 44 Total Visits, 32 office visits and 21 phone call visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Resistant Hypertension
Facility: 395 Williamson Rd
Age: >18
Gender: M/F
Enrollment: Starting in May 2025
Commitment Duration: up to 4 weeks
Number of Visits in study: up to 3 visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Patients with type 2 diabetes, hypertension and established cardiovascular disease
Age: >18
Gender: M/F
Enrollment: Starting in July 2025
Commitment Duration: 1.5 years
Number of Visits in study: 14 Visits: 9 Office visits and 5 phone call visits
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
*In partnership with Accellacare*
Medical Condition: Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Facility: 208 Old Mocksville Rd
Age: >45
Gender: M/F
Enrollment: Starting in July 2025
Commitment Duration: 5 years, includes a 2-year open label extension
Number of Visits in study: 39 Office visits and every 4 weeks phone call visit
Patient compensation will be available: Compensation will be available
For additional inquiries or if you have any questions, please call 704-924-2105 or email Nicole.Everhart@accellacare.com
Piedmont HealthCare is proud to partner with Accellacare & Innovo Research to conduct clinical studies.
To learn more about our partners, follow the links below.